YOLFTbeta
The Calmer Co International Ltd

The Calmer Co International Ltd

CCO · AU · Consumer Defensive / Packaged Foods

0.001AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.001
Open0.001
Day Range0.001 – 0.001
52-Week Range0.001 – 0.005
Volume8.10M
Market Cap5.34M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.63
50-Day Avg0.0011
200-Day Avg0.0025

About

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It operates through four segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in Yeronga, Australia.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Zane Yoshida B.Tech., M.B.A.
  • Employees0
  • Headquarters24 Cansdale Street, Yeronga, QLD, Australia, 4104, Australia
  • Websitehttps://www.thecalmerco.com

Leadership

  • Mr. Zane Yoshida B.Tech., M.B.A.Founder, COO, MD, CEO & Executive Director
  • Mr. Pravinesh LalaChief Financial Officer
  • Prof. Jerome SarrisMember Scientific Advisory Board & Chief Scientist
  • Mr. Brian CasuttoManaging Director of FijiKava Inc (USA) · b. 1971
  • Mr. Andy BurgerHead of E-Commerce
  • Mr. Matthew KowalChief Commercial Officer
  • Ms. Natalie Sylvia Climo L.L.B.Company Secretary

Financials

Income Statement

Currency: AUD2015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue---3.96K149.11K758.87K1.16M2.05M1.78M4.26M8.03M8.12M
Growth (%)----+3665.45%+408.92%+52.88%+76.76%-13.00%+138.92%+88.48%+1.01%
Cost of Revenue---2.06K83.96K574.54K755.73K1.42M3.19M2.21M4.55M7.29M
Gross Profit---1.90K65.16K184.33K404.43K236.14K-1.40M2.05M3.48M828.54K
Gross Margin---47.93%43.70%24.29%34.86%11.51%-78.69%48.08%43.33%10.21%
Operating Expense---323.84K4.72M3.88M3.93M5.71M3.00M3.93M5.68M4.22M
Operating Income-1.93K-4.37K-51.81K-321.94K-4.66M-3.69M-3.53M-5.48M-4.41M-1.88M-2.20M-3.39M
Operating Margin----8129.80%-3123.86%-486.86%-303.92%-267.02%-247.10%-44.19%-27.33%-41.77%
EBITDA-1.13K-2.12K-101.81K-321.36K-4.77M-3.56M-3.19M-5.72M-4.86M-3.34M-3.45M-3.00M
EBITDA Margin----8115.23%-3198.75%-468.89%-274.69%-278.86%-272.40%-78.35%-42.93%-36.97%
Net Income-3.06K-4.37K-101.96K-386.25K-4.67M-3.77M-3.39M-5.92M-5.24M-3.73M-3.99M-3.81M
Net Income Margin----9753.86%-3129.21%-496.32%-292.24%-288.49%-293.79%-87.42%-49.69%-46.92%
R&D---59310.96K101.09K137.85K44.29K1.82K10.28K16.00K376.79K
R&D as % of Total Revenue---14.97%7.35%13.32%11.88%2.16%0.10%0.24%0.20%4.64%
Interest Expense--15558.64K13.86K42.57K46.69K60.47K269.70K173.35K203.62K370.25K
Interest Expense % of Total Revenue---1480.88%9.30%5.61%4.02%2.95%15.12%4.07%2.53%4.56%

Balance Sheet

Currency: AUD2015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets2110.38K82.69K11.76M3.56M2.95M3.60M4.79M3.24M4.33M5.68M4.91M
Total Liabilities3.57K5.82K80.09K494.14K474.10K1.56M694.78K2.51M3.32M4.80M3.78M5.36M
Total Equity-3.57K104.56K2.60K11.27M3.09M1.38M2.91M2.28M-87.53K-466.84K1.90M-451.34K
Cash2110.38K60.43K4.82M2.32M1.43M1.18M799.22K430.98K1.10M1.46M668.73K
Total Debt1.32K1.32K1.32K5.14K1.32K909.72K175.13K1.67M2.35M2.21M2.31M3.88M
Net Debt1.32K-109.06K-59.11K-4.81M-2.32M-679.85K-1.06M278.21K1.92M1.11M849.57K3.21M

Cash Flow

Currency: AUD2015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-1.13K-2.12K-2.02K-162.94K-2.21M-3.54M-4.14M-6.14M-3.80M-2.08M-4.37M-2.94M
Investing Cash Flow---67.93K-1.23K4.50M-135.57K-259.37K-964.94K-21.08K-116.97K-459.91K-47.14K
Financing Cash Flow1.13K112.50K20.00K169.11K-2.79M4.16M6.74M3.47M2.83M5.19M2.19M
Capital Expenditure0001.23K405.72K135.57K259.37K964.94K21.08K116.97K459.91K47.14K
Free Cash Flow-1.13K-2.12K-2.02K-164.17K-2.62M-3.67M-4.40M-7.10M-3.82M-2.19M-4.83M-2.98M
FCF to OCF100.00%100.00%100.00%100.76%118.36%103.83%106.26%115.73%100.55%105.55%110.52%101.61%

Earnings

Report DateSep 30, 2019Mar 2, 2020Aug 31, 2020Feb 17, 2021Aug 31, 2021Feb 28, 2022Aug 31, 2022Feb 28, 2023Apr 30, 2024Aug 30, 2024Oct 29, 2024Feb 28, 2025Apr 29, 2025Aug 28, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.02-0.03-0.02-0.01-0.01-0.02-0.02-0.010.000.000.000.000.000.000.00
Surprise---------------
Timing-------After-hours----After-hours--

Key Statistics & Ratios

Market Cap5.34M
Enterprise Value8.55M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.66
Price / Book28.50
EPS0.00
Book Value0.00
Revenue (TTM)8.12M
Gross Profit (TTM)2.78M
EBITDA-3.11M
Profit Margin-46.92%
Operating Margin-47.10%
Return on Equity-524.61%
Return on Assets-39.04%
Shares Outstanding5.34B
Shares Float2.24B
Beta0.63
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 5, 20241.0909:1